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Transesophageal Echocardiography in the
Detection of Prosthetic Mitral Valve
Thrombosis Caused by Inadequate
Anticoagulation
Yung-Chih Chen, Ta-Chun Hong1 and Charles Jia-Yin Hou
Intracranial hemorrhage resulting from oral anticoagulation in patients with prosthetic
heart valves is rare. If it occurs, however, the anticoagulation treatment should be
immediately reversed. The difficulty is to decide when to resume treatment. Without
anticoagulation, the patient is at high risk of valve thrombosis and systemic
embolization. We report a patient with a prosthetic mitral valve who developed
intracranial hemorrhage as a complication of anticoagulation. Reinstitution of warfarin
was delayed, and she developed severe valvular thrombosis with pulmonary edema.
This was promptly diagnosed using bedside transesophageal echocardiography, and
surgery was successfully carried out. Warfarin was restarted 4 days after surgery
without further sequelae.
(J Med Ultrasound 2003;11:111–4)
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CASE REPORT
A 49-year-old woman with rheumatic heart disease
and mitral stenosis had had mechanical valve
replacement 5 years previously. Before surgery, she
had had functional class II congestive heart failure.
There was no history of hypertension. She received
oral anticoagulation (warfarin) with careful
monitoring of the prothrombin time to maintain an
international normalized ratio (INR) of between 2
and 3.
She arrived in our emergency department after
sudden loss of consciousness at home. Brain
computed tomography without contrast revealed a
huge intracranial hemorrhage (ICH) in the left
hemisphere (Fig. 1). A review of her history indicated
that she had been taking an irregular dose of warfarin
and that she had not attended follow-up clinics in
the previous month. Her INR was found to be elevated
(37.7). The anticoagulation was reversed and she
successfully underwent craniotomy for evacuation of
the hemorrhage. No further intracranial bleeding
occurred after surgery. A transthoracic echocardio-
gram (TTE) performed just after surgery revealed
a mildly enlarged left atrium (42 mm) and a left
ventricular ejection fraction of 70%. The mitral valve
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orifice measured about 3 cm to 3.5 cm in diameter,
and the pressure gradient was 9.8 mmHg.
Approximately 6 weeks after surgery, she
developed dyspnea. Arterial blood gases showed
severe hypoxemia (PaO2: 51.4%) with respiratory
alkalosis. Chest radiography after intubation and
mechanical ventilation revealed bilateral homo-
geneous alveolar infiltrates. There was mild leuko-
cytosis, but she was afebrile. An electrocardiogram
showed sinus tachycardia with low QRS voltage in
the limb leads. Swan-Ganz data indicated elevated
pulmonary arterial pressure (77 mmHg) and
pulmonary arterial wedge pressure (42 mmHg). A
repeat TTE demonstrated a diminished mitral valve
orifice of about 1.5 cm in diameter, by continuity
equation, with abnormal echodense material
obstructing the mitral orifice during the diastolic
phase. An elevated transmitral pressure gradient
of about 46 mmHg and severe pulmonary hyper-
tension estimated to be 77 mmHg were also ob-
served. There was paradoxical septal wall motion
and right ventricular enlargement (28 mmHg), but
no obvious wall-motion abnormality. In order to
obtain a better picture of the valve, transesopha-
geal echocardiography (TEE) was arranged. This
demonstrated the adhesion on the left atrial side
of a large organized thrombus to the anterior me-
chanical mitral leaflet. There was no disc motion
interference, but left ventricular diastolic filling was
interrupted. In addition, a diminished central jet
was seen from the mid-esophageal long-axis view
(Figs. 2–4). Posterior leaflet movement was intermit-
tently limited by a small thrombus obstructing the
inflow orifice of the mitral area.
Fig. 1. An area of hyperdensity in the left cerebral
hemisphere demonstrates intracranial hemorrhage on
computed tomography with mass effect and subsequent
midline shift.
Fig. 2. The white arrow indicates a large thrombus over
the anterior mechanical mitral valve with obstruction of
flow. The black arrow shows the original intact mechanical
valve leaflet.
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Emergency mitral valve replacement was per-
formed with cardiopulmonary bypass. A large
thrombus was found on the anterior leaflet (Fig. 5).
The patient recovered well from surgery and was
successfully extubated soon after the operation. Chest
radiography 2 days later revealed rapid improvement
of the pulmonary edema. Oral anticoagulation was
restarted 4 days after surgery. There was no further
intracranial bleeding, and the patient was discharged
2 weeks after the operation.
DISCUSSION
Acute dysfunction of the prosthetic valve, either be-
cause of annular dehiscence with valvular regurgi-
tation or leaflet thrombosis with acute occlusion, may
lead to an abrupt reduction in cardiac output, refrac-
tory cardiogenic shock, and/or pulmonary edema.
Fig. 3. Transmitral inflow area shows an obvious Doppler
pressure-gradient flow pattern resulting from severe ob-
struction of mitral inflow secondary to thrombus formation.
Fig. 4. Color Doppler revealed an obscure mosaic flow
pattern due to turbulent flow through a stenotic mitral
area with aliasing velocity limitation (white arrow).
On echocardiography, our patient had a demonstrable
mitral valve thrombosis with obstruction of flow,
an elevated transvalvular gradient, no wall-motion
abnormality, severe pulmonary hypertension with
paradoxical septal wall motion, and right ventricular
enlargement. These findings were all consistent with
an obstructing valve thrombus being the sole cause
of a sudden, severe decrease in cardiac output with
a compensatory tachycardia.
Echocardiography performed in such situations is
quite helpful and is non-invasive. TEE, as this case
demonstrates, plays a more important role in the
greater understanding of cause than TTE. The tradi-
tional measurement of transvalvular velocities across
prosthetic valves is not always accurate, as different
volume flow rates reasonably lead to different
estimations of the stenotic prosthetic valve area. The
pressure half-time method under these conditions
may be related to different flow rates and is, thus,
not independent. Use of the continuity equation
method in the evaluation of prosthetic valve area
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may be more accurate and practical because it is
relatively more independent of the volume flow rate
being affected by various pathophysiologic condi-
tions. It assumes that the forward stroke volume
throughout the heart is equal, and a given cross-
section area times regional velocity determines the
same flow rate anywhere.
The recommended INR to prevent thrombo-
embolism with prosthetic heart valves (PHVs) is
between 3.5 and 4.5 [1]. However, this confers a
4- to 10-fold increased risk of ICH as a potentially
fatal complication. It is reported to occur with a
frequency of 1% per patient-year [2]. Profound
prolongation of the INR (37.7) was the most likely
cause of the ICH in our patient, as she had neither
a history of hypertension nor an elevated blood
pressure on admission for her ICH [3].
No large-scale studies have yet addressed the
question of how long anticoagulant treatment can
be safely withheld in a patient with a PHV [4].
According to Cannegieter et al, the risk of embolism
from PHVs resulting in major stroke or death is 4%
a year, and the risk of valve thrombosis is 1.8% a
year [5]. Crawley et al gave estimates for risk assess-
ment when anticoagulation is withheld [6]. Stop-
ping anticoagulation for 6 weeks, as in our case,
would theoretically carry a risk of embolism of
about 0.67%, with a daily risk of 0.016%. Butler
and Tait studied 35 patients with oral anticoagulant-
related ICH and concluded that temporary cessation
of anticoagulation therapy (mean, 7 days) is safe [7].
Our patient was off warfarin for much longer than
this, which undoubtedly increased her risk.
The exact cause of the acute pulmonary edema
was promptly identified by use of bedside TEE, and
early surgery provided a better outcome. TEE enabled
specific and precise morphologic observation and
delineation of the mitral valve structure. This is
especially relevant when a prosthetic valve implant
causes reverberation and acoustic shadow, obscuring
what may be seen on traditional TTE.
CONCLUSION
We suggest the need for large prospective trials to
help resolve the problem of when anticoagulation
treatment should be restarted after neurosurgery in
a patient with a prosthetic mitral valve. Focus should
be on the proper and accurate findings of intracardiac
structure and morphology, enabling full diagnosis
and the opportunity for rapid management. While
traditional TTE offers useful information, early
intervention with TEE, with its precise anatomic
resolution, saves time and may save a life.
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Fig. 5. A huge thrombus over the mechanical mitral valve
was found during surgery (left) and removed together
with the mechanical valve (right).
